Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Groupe Bruxelles Lambert S.A
Acquired Company
Recordati S.p.A
Brussels
MilanFinancial ServicesVenture CapitalAngel InvestmentManufacturingDescription
Groupe Bruxelles Lambert S.A. has increased its takeover offer for Recordati S.p.A. to EUR 53.00 per share. The revised bid enhances the company's position in the pharmaceutical market and extends the acceptance period to October 23, 2026. This strategic acquisition aims to leverage GBL's financial strengths and market reach.
Fundz sees it the moment Groupe Bruxelles Lambert S.A makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Recordati S.p.A?
Recordati S.p.A was acquired by Groupe Bruxelles Lambert S.A, based in Brussels. The deal was reported on October 15, 2026. Groupe Bruxelles Lambert S.A. is an investment holding company that manages a diversified portfolio of businesses. It focuses on long-term value creation through strategic investments in various industries. Groupe Bruxelles Lambert S.A is privately held and operates in Financial Services.
When did Groupe Bruxelles Lambert S.A acquire Recordati S.p.A?
Groupe Bruxelles Lambert S.A's acquisition of Recordati S.p.A was reported on October 15, 2026. Groupe Bruxelles Lambert S.A. has increased its takeover offer for Recordati S.p.A. to EUR 53.00 per share. The revised bid enhances the company's position in the pharmaceutical market and extends the acceptance period to October 23, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Recordati S.p.A do?
Recordati S.p.A. is an Italian specialty pharmaceutical group focused on rare diseases and other therapeutic areas. The company generates most of its revenue from prescription medicines and has a vertically integrated model. It is privately held, operating in Manufacturing, and is based in Milan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.